Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes

After examining the complex interplay between heart failure (HF) in its various clinical forms, metabolic disorders like nonalcoholic fatty liver disease (NAFLD), and obstructive sleep apnea (OSA) syndrome, in this mini-review we described possible favorable effects of sodium–glucose cotransporter 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Monda, Vincenzo Maria, Gentile, Sandro, Porcellati, Francesca, Satta, Ersilia, Fucili, Alessandro, Monesi, Marcello, Strollo, Felice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525351/
https://www.ncbi.nlm.nih.gov/pubmed/36112311
http://dx.doi.org/10.1007/s12325-022-02310-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525351/
https://www.ncbi.nlm.nih.gov/pubmed/36112311
http://dx.doi.org/10.1007/s12325-022-02310-2

Ejemplares similares